A new report co-authored by Cornell researchers highlights significant vulnerabilities in the U.S. baby formula supply chain, following the critical shortage of powdered infant formula in 2022. The National Academies of Sciences, Engineering, and Medicine’s consensus study, published on July 25, underscores the need for enhanced resiliency planning to prevent future disruptions, particularly for the most vulnerable populations.
The report, prompted by a nationwide shortage triggered by contamination at an Abbott Nutrition plant, found that the Food and Drug Administration (FDA) should mandate redundancy risk management plans from formula manufacturers. The study also pointed to the high reliance on infant formula in the U.S., suggesting that increased breastfeeding could serve as a buffer during shortages.
Cornell’s Kathleen Rasmussen, a co-author, emphasized that the consolidation of formula production among a few manufacturers, combined with outdated facilities, exacerbates the risk of supply chain failures. The report also calls for clearer messaging to parents about the preparation and risks associated with powdered formula, which lacks the sterilization process used in liquid formula.
The findings have spurred the FDA to consider regulatory changes to strengthen food safety protocols and safeguard the formula supply chain against future crises.
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to news@fingerlakes1.com.